Klebsiella pneumoniae ipervirulenta: una nuova emergenza? L’esperienza della Fondazione IRCCS Policlinico San Matteo di Pavia
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Not available.
European Centre for Disease Prevention and Control. Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries. Available at: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-emergence-hypervirulent-klebsiella-pneumoniae-eu-eea
Scaltriti et al. Detection of a hypermucoviscous Klebsiella pneumoniae co producing NDM 5 and OXA 48 carbapenemases with sequence type 383, Brescia, Italy. Int J Antimicrob Agents. 2020;56:106130. DOI: https://doi.org/10.1016/j.ijantimicag.2020.106130
Lorenzin et al. Detection of NDM 1/5 and OXA 48 co producing extensively drug resistant hypervirulent Klebsiella pneumoniae in Northern Italy. J Glob Antimicrob Resist. 2022;28:146-150. DOI: https://doi.org/10.1016/j.jgar.2022.01.001
Falcone M et al. Spread of hypervirulent multidrug resistant ST147 Klebsiella pneumoniae in patients with severe COVID 19: an observational study from Italy, 2020-21. J Antimicrob Chemother. 2022;77:1140-1145. DOI: https://doi.org/10.1093/jac/dkab495
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.